Analysts expect Tenaya Therapeutics, Inc. to report revenue of 820,624.00 for Q3 26, against a range of 767,254.72 to 873,993.28. The most recent reported quarter, Q2 26, came in at 1.11 M, a 89.3% miss against the 10.37 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 225,000.00 | 1.11 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.79 M | 10.80 M | 873,993.28 | 2.85 M | 1.44 M | 1.39 M | 972,539.93 | 2.37 M | 307,212.00 | 292,226.40 | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.62 M | 9.94 M | 767,254.72 | 2.42 M | 1.26 M | 1.24 M | 882,392.09 | 2.12 M | 263,010.62 | 273,362.32 | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.20 M | 10.37 M | 820,624.00 | 2.63 M | 1.35 M | 1.32 M | 927,466.01 | 2.24 M | 285,111.31 | 282,794.36 |
Analysts expect Tenaya Therapeutics, Inc. to report earnings per share of -0.09 for Q3 26, against a range of -0.10 to -0.08. The most recent reported quarter, Q2 26, came in at -0.20, a 185.7% miss against the -0.07 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.30 | -0.28 | -0.24 | -0.14 | -0.12 | -0.12 | -0.09 | -0.20 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.35 | -0.31 | -0.17 | -0.17 | -0.14 | -0.12 | -0.09 | -0.06 | -0.08 | -0.08 | -0.10 | -0.09 | -0.04 | -0.05 | 0.04 | 0.04 | ||||||||||
| Low Estimate | -0.41 | -0.33 | -0.19 | -0.19 | -0.16 | -0.14 | -0.09 | -0.08 | -0.10 | -0.10 | -0.10 | -0.11 | -0.04 | -0.05 | 0.04 | 0.04 | ||||||||||
| Consensus Estimate | -0.38 | -0.32 | -0.18 | -0.18 | -0.15 | -0.13 | -0.09 | -0.07 | -0.09 | -0.09 | -0.10 | -0.10 | -0.04 | -0.05 | 0.04 | 0.04 |
Pull Wall Street consensus for Tenaya Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=TNYA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "TNYA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=TNYA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();